Reve Technologies, Inc. (OTCMKTS:BSSP) Short Interest Update


Share on StockTwits

Reve Technologies, Inc. (OTCMKTS:BSSP) was the recipient of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 59,700 shares, a decline of 50.2% from the March 15th total of 119,800 shares. Based on an average daily volume of 87,156,100 shares, the short-interest ratio is currently 0.0 days.

Shares of OTCMKTS BSSP opened at $0.00 on Friday. Reve Technologies has a 52-week low of $0.00 and a 52-week high of $0.00.

About Reve Technologies

Reve Technologies, Inc, a drug development company, provides advanced therapeutics for the treatment of cancer. It offers irreversible pepsin fraction (IPF), a therapeutic platform technology that is used to facilitate a range of applications. The company's solution is also used for the treatment of autoimmune diseases, such as cirrhosis and Hepatitis C.

Recommended Story: What is the Russell 2000 Index?

Receive News & Ratings for Reve Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reve Technologies and related companies with MarketBeat.com's FREE daily email newsletter.